TrialBone2010

The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: a 2-year trial.

G J van Londen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.